PM250103C140000
- 0.03
- 0.000.00%
Philip Morris International Newsroom
Netflix, United Airlines, and More to Watch This Week
BofA's Best Financial, Consumer Stock Ideas for 2025: WFC, SBUX, More
ZYN Nicotine Pouches Receive FDA Marketing Approval
Philip Morris International Inc. (PM): A Bull Case Theory
Today's Analyst Rating | NVIDIA Price Target Raised to $175 by Barclays, Taiwan Semiconductor Price Target Raised to $255 by Barclays
Jan 17, Wall Street analysts have updated their stock ratings today including $NVIDIA(NVDA.US)$ and $Taiwan Semiconductor(TSM.US)$.
BofA Securities Maintains Philip Morris International(PM.US) With Buy Rating, Maintains Target Price $143
Barclays Maintains Philip Morris International(PM.US) With Buy Rating, Maintains Target Price $145
Philip Morris's Zyn Nicotine Pouch Isn't Safe, but FDA Gives OK to Marketing It
UBS Maintains Philip Morris International(PM.US) With Sell Rating, Raises Target Price to $105
Philip Morris Shares Advance 1% After FDA Authorizes Marketing of Zyn
FDA Allows Flavored Zyn Nicotine Pouches to Stay on the Market -- WSJ
Least Shorted S&P 500 Stocks in December
FDA Authorizes Marketing Of 20 ZYN Nicotine Pouch Products After Extensive Scientific Review
This Philip Morris International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Philip Morris Price Target Announced at $140.00/Share by Morgan Stanley
Philip Morris Initiated at Overweight by Morgan Stanley
Morgan Stanley Initiates Philip Morris International(PM.US) With Buy Rating, Announces Target Price $140
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
Bets Against Consumer Staples Rise in December: Walgreens, Campbell Among Most Shorted
US FDA Proposes Reducing Nicotine Limits in Cigarettes; Philip Morris, Altria Shares Slip